Michael Stecher

1.1k citations
19 papers · 864 · 1 hit paper · h-index 11

Impact in

  • Oncology top 10%
    • Colorectal Cancer Treatments and Studies
    • Cytokine Signaling Pathways and Interactions
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Hidradenitis Suppurativa and Treatments

Papers in

    • Colorectal Cancer Treatments and Studies 11
    • Cancer Immunotherapy and Biomarkers 2
    • HER2/EGFR in Cancer Research 2
    • Cytokine Signaling Pathways and Interactions 1
    • Hidradenitis Suppurativa and Treatments 1

Michael Stecher

19 papers receiving 849 citations

Michael Stecher's Hit Papers

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study 2023 · 183 citations
1830+1+2Years since publication50100150

Peers

Michael Stecher
Comparison fields: 5 of 59
  • Oncology 374
  • Dermatology 108
  • Immunology 167
  • Physiology 105
  • Biological Psychiatry 4
Replace Kayoko Kibata with:
Kayoko Kibata Japan
Lutz Kretschmer Germany
Erin Gatza United States
Toshihisa Hamada Japan
Narelle Woodland Australia
Sayaka Hayashida Japan
Takuya Komeno Japan
Hidenori Sasaki Japan
David J. Swan United Kingdom
Mitsuo Kozuru Japan
Michael Stecher relative to Kayoko Kibata Japan Kayoko Kibata's profile →
Citations per field
00.5×2×3×3.5×
Kayoko Kibata · 1×
Citations per year

Countries citing papers authored by Michael Stecher

Since Specialization
Citations

This map shows the geographic impact of Michael Stecher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stecher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stecher more than expected).

Fields of papers citing papers by Michael Stecher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Stecher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stecher. The network helps show where Michael Stecher may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Stecher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Stecher Line = papers co-authored together Michael Stecher links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
Hit paper breakdown →
2023183
2 2014180
3 2017148
4 201799
5 201563
6 201843
7 201541
8 201524
9 201622
10 202220
11 202314
12
An Open Label, Phase 2 Study of MABp1 Monotherapy for the Treatment of Acne Vulgaris and Psychiatric Comorbidity.
201511
13 20236
14 20213
15 20233
16 20161
17 20201
18 20211
19 20221

About Michael Stecher

Michael Stecher is a scholar working on Oncology, Dermatology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Immunology, having authored 19 papers that have together received 864 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), HER2/EGFR in Cancer Research (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Lung Cancer Treatments and Mutations (1 paper), Hidradenitis Suppurativa and Treatments (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Oncology (374 citations), Dermatology (108 citations), Immunology (167 citations), Physiology (105 citations) and Biological Psychiatry (4 citations). Michael Stecher has collaborated with scholars based in United States, France and Spain. Frequent co-authors include John J. L. Simard, Razelle Kurzrock, Sarina Anne Piha-Paul, Jennifer J. Wheler, David S. Hong, Apostolia Maria Tsimberidou, Filip Jankú, Gerald Steven Falchook, Aung Naing and Siqing Fu. Their work appears in journals such as Annals of Oncology, The Lancet Oncology, Open Forum Infectious Diseases, JAMA Dermatology and Journal of Investigative Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact